Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 07, 2018 16:01 ET | Source: Celldex Therapeutics, Inc.

Celldex Provides Corporate Update and Reports Full Year 2017 Results

HAMPTON, N.J., March 07, 2018 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported business and financial highlights for the fourth quarter and year ended December 31, 2017....
March 02, 2018 15:15 ET | Source: Celldex Therapeutics, Inc.

Celldex to Report Fourth Quarter and Year-End 2017 Business/Financial Results and Present at Upcoming Investor Conference

HAMPTON, N.J., March 02, 2018 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Nasdaq:CLDX) announced today upcoming investor events in March. 2017 Year-End Results and Conference Call/Webcast ...
November 30, 2017 08:01 ET | Source: Celldex Therapeutics, Inc.

Celldex Therapeutics Initiates Phase 1 Study of New Product Candidate CDX-1140 in Solid Tumors

HAMPTON, N.J., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Nasdaq:CLDX) announced today that enrollment has opened in its open-label, Phase 1 study of CDX-1140 in patients with...
November 17, 2017 08:01 ET | Source: Celldex Therapeutics, Inc.

Celldex Therapeutics Initiates Phase 2 Combination Study of CDX-3379 and Cetuximab in Head and Neck Squamous Cell Carcinoma

HAMPTON, N.J., Nov. 17, 2017 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Nasdaq:CLDX) announced today that enrollment has opened in its open-label Phase 2 study of CDX-3379 in combination with...
November 07, 2017 08:01 ET | Source: Celldex Therapeutics, Inc.

Celldex Reports Third Quarter 2017 Results

HAMPTON, N.J., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported business and financial highlights for the third quarter ended September 30, 2017. "In late...
October 03, 2017 08:00 ET | Source: Celldex Therapeutics, Inc.

Celldex Therapeutics Appoints Margo Heath-Chiozzi, M.D., as Senior Vice President, Regulatory Affairs

HAMPTON, N.J., Oct. 03, 2017 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that Margo Heath-Chiozzi, M.D., has joined the Company as Senior Vice President, Regulatory...
September 22, 2017 08:00 ET | Source: Celldex Therapeutics, Inc.

Celldex Therapeutics to Present at the Cantor Fitzgerald Global Healthcare Conference

HAMPTON, N.J., Sept. 22, 2017 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that Anthony Marucci, Co-founder, President and Chief Executive Officer, will present a...
September 12, 2017 16:01 ET | Source: Celldex Therapeutics, Inc.

Celldex Announces Departure of Chief Medical Officer

HAMPTON, N.J., Sept. 12, 2017 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today the resignation of Thomas Davis, M.D., Executive Vice President and Chief Medical Officer...
August 23, 2017 09:15 ET | Source: Celldex Therapeutics, Inc.

Celldex Announces Completion of Enrollment in Phase 2b Study of Glembatumumab Vedotin in Triple Negative Breast Cancer

HAMPTON, N.J., Aug. 23, 2017 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that patient enrollment has been completed in the Company's Phase 2b METRIC study of...
August 08, 2017 16:01 ET | Source: Celldex Therapeutics, Inc.

Celldex Reports Second Quarter 2017 Results

HAMPTON, N.J., Aug. 08, 2017 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported business and financial highlights for the second quarter ended June 30, 2017. "In the second...